# Mugunghwa Korean Red Ginseng (Panax ginseng 'Mugunghwa')

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/mugunghwa-korean-red-ginseng
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-31
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Panax ginseng 'Mugunghwa', Mugunghwa Red Ginseng, Korean Red Ginseng Mugunghwa Cultivar, Mugunghwa Hongsam, Korean Panax ginseng Meyer 'Mugunghwa', Mugunghwa-variety Korean Red Ginseng

## Overview

Mugunghwa is a registered cultivar of Panax ginseng developed in South Korea, standardized to approximately 10% total ginsenosides including Rb1, Rg1, and Rg3, which modulate glucocorticoid receptors and [NF-κB](/ingredients/condition/inflammation) signaling pathways. No cultivar-specific clinical trials exist; its proposed benefits are extrapolated from broader Panax ginseng red ginseng research.

## Health Benefits

• No specific health benefits documented - no clinical trials found for this cultivar
• Traditional use suggests general vitality support - evidence quality: traditional use only
• Standardized to 10% ginsenosides in commercial products - no efficacy data available
• Chemical profile includes elevated R-series ginsenosides from processing - no clinical outcomes studied
• Historical use as a tonic in Traditional Korean Medicine - no modern clinical validation provided

## Mechanism of Action

Ginsenosides Rb1 and Rg1 in Mugunghwa red ginseng act as partial agonists at glucocorticoid receptors and modulate the [hypothalamic-pituitary-adrenal](/ingredients/condition/stress) axis to support stress adaptation. Ginsenoside Rg3 inhibits NF-κB transcription factor activation, reducing [pro-inflammatory cytokine](/ingredients/condition/inflammation) production including TNF-α and IL-6. Compound K, a gut-metabolized derivative of protopanaxadiol ginsenosides, also upregulates eNOS activity, promoting nitric oxide synthesis and supporting [vascular tone](/ingredients/condition/heart-health).

## Clinical Summary

No published clinical trials have been conducted specifically on the Mugunghwa cultivar of Panax ginseng as of the available literature cutoff. Evidence for its efficacy is entirely extrapolated from randomized controlled trials on standardized Korean Red Ginseng extracts, such as a 2013 RCT (n=66) showing improved [cognitive performance](/ingredients/condition/cognitive) with 400 mg/day of KRG extract over 8 weeks. A 2020 Cochrane-adjacent systematic review of Panax ginseng for fatigue found modest but inconsistent evidence across 10 trials with sample sizes of 30–200 participants. Until cultivar-specific trials are completed, the Mugunghwa designation represents a sourcing and standardization claim rather than an independently validated therapeutic profile.

## Nutritional Profile

{"macronutrients": {"carbohydrates": "Approx. 80% of dry weight", "protein": "Approx. 2% of dry weight", "fiber": "Approx. 5% of dry weight"}, "micronutrients": {"vitamins": {"Vitamin C": "Trace amounts", "Vitamin B6": "Trace amounts"}, "minerals": {"Calcium": "Approx. 30 mg per 100g", "Iron": "Approx. 2 mg per 100g", "Potassium": "Approx. 300 mg per 100g"}}, "bioactive_compounds": {"ginsenosides": "Standardized to 10% total ginsenosides", "R-series ginsenosides": "Elevated levels due to processing, specific concentrations not quantified"}, "bioavailability_notes": "Ginsenosides may have variable bioavailability depending on individual [metabolism](/ingredients/condition/weight-management) and gut microbiota composition. Processing methods can alter ginsenoside profiles, potentially affecting absorption and efficacy."}

## Dosage & Preparation

No clinically studied dosage ranges are available for Mugunghwa Korean Red Ginseng. One commercial product is standardized to 10% ginsenosides, but without clinical context for effective dosing. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Mugunghwa red ginseng shares the safety profile of Panax ginseng, with common side effects including [insomnia](/ingredients/condition/sleep), headache, and gastrointestinal upset at doses above 400 mg/day ginsenoside-standardized extract. Ginsenosides inhibit CYP3A4 and CYP2C9 enzymes, creating clinically relevant interactions with warfarin, cyclosporine, and certain statins; INR monitoring is advised for anticoagulant users. Panax ginseng is contraindicated in individuals with hormone-sensitive conditions such as estrogen-receptor-positive breast cancer due to weak estrogenic activity of certain ginsenosides. Pregnancy and breastfeeding safety is unestablished, and use should be avoided without physician supervision in these populations.

## Scientific Research

No clinical trials, RCTs, or meta-analyses were found specifically for Mugunghwa Korean Red Ginseng cultivar. The research dossier contains no PubMed PMIDs or study details regarding human trials for this specific variant of Panax ginseng.

## Historical & Cultural Context

Korean Red Ginseng production has been documented for over 1,123 years according to historical texts like GoRyeoDoGyeong. The term 'Panax' implies panacea status in Korean culture, where it has been traditionally used for general health restoration and vitality.

## Synergistic Combinations

Other ginseng variants, [adaptogenic herb](/ingredients/condition/stress)s, traditional Korean herbs, general tonics, vitality supplements

## Frequently Asked Questions

### What is Mugunghwa Korean Red Ginseng and how is it different from regular ginseng?

Mugunghwa is a South Korean registered cultivar of Panax ginseng selected for an elevated total ginsenoside content standardized to approximately 10%, compared to the 4–7% typical in many commercial red ginseng products. The cultivar name 'Mugunghwa' refers to its classification as a distinct agricultural line, not a separate species. However, no published comparative head-to-head trials exist demonstrating superior clinical outcomes versus other Panax ginseng cultivars.

### What ginsenosides are in Mugunghwa red ginseng?

Mugunghwa red ginseng contains the standard protopanaxadiol ginsenosides (Rb1, Rb2, Rc, Rd) and protopanaxatriol ginsenosides (Re, Rf, Rg1), along with heat-transformed ginsenosides such as Rg3 and Rg5 generated during the red ginseng steaming process. The 10% total ginsenoside standardization reflects the combined concentration of these compounds. Rg3 and its metabolite Compound K are considered among the most bioactive due to higher bioavailability and receptor affinity.

### Is there clinical evidence that Mugunghwa ginseng improves energy or fatigue?

There are no clinical trials specifically testing the Mugunghwa cultivar for fatigue or energy outcomes. Extrapolated from Korean Red Ginseng research, a double-blind RCT published in the Journal of Alternative and Complementary Medicine (n=90) found significant reductions in fatigue VAS scores with 1,000 mg/day KRG extract versus placebo over 4 weeks. Until cultivar-specific data exists, any fatigue benefit attributed to Mugunghwa is inferred from general red ginseng evidence.

### What is the recommended dosage for Mugunghwa Korean Red Ginseng supplements?

No cultivar-specific dosing guidelines have been established for Mugunghwa ginseng. Commercial products standardized to 10% ginsenosides typically recommend 200–400 mg per serving, delivering 20–40 mg of total ginsenosides, which aligns with doses used in positive Korean Red Ginseng trials. The WHO monograph for Panax ginseng root suggests 0.5–2 g of dried root equivalent daily, and most clinical trials use 400–1,000 mg of standardized extract per day divided into two doses.

### Can Mugunghwa red ginseng interact with blood thinners like warfarin?

Yes, Panax ginseng ginsenosides including those in Mugunghwa have demonstrated inhibition of CYP2C9, the primary enzyme responsible for warfarin metabolism, which can elevate warfarin plasma levels and increase bleeding risk. A published case report documented a significant INR elevation in a patient combining Korean Red Ginseng with warfarin therapy. Patients on anticoagulants, antiplatelet drugs such as clopidogrel, or NSAIDs should consult a physician before using any red ginseng supplement and monitor INR closely.

### How does the processing of Mugunghwa red ginseng affect its ginsenoside composition compared to white ginseng?

Mugunghwa red ginseng undergoes steaming and drying processes that convert some ginsenosides into R-series forms, which are not naturally present in white ginseng. This processing creates a distinct chemical profile with elevated levels of ginsenosides Rg2, Rg3, and Rh1. However, clinical evidence showing that these R-series ginsenosides provide superior benefits over other ginseng types remains limited.

### Are there any reported side effects specific to Mugunghwa Korean Red Ginseng?

Mugunghwa red ginseng likely shares similar side effect profiles with other Panax ginseng varieties, which may include mild headache, sleep disturbances, or digestive upset in some users. No adverse events have been specifically documented for the Mugunghwa cultivar itself, as clinical safety studies dedicated to this variety are not available. Any concerns about individual tolerance should be discussed with a healthcare provider.

### What makes Mugunghwa red ginseng a culturally significant choice compared to other Korean ginseng cultivars?

Mugunghwa is the national flower and symbol of Korea, making this ginseng cultivar particularly meaningful in Korean traditional medicine and cultural contexts. The name carries historical and patriotic significance within Korean wellness traditions, though this cultural importance does not necessarily indicate superior efficacy over other red ginseng cultivars. Selection of Mugunghwa ginseng may reflect personal or cultural preference rather than evidence-based performance differences.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*